A5007072861- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Mechanisms and Therapy
- Nonlinear Optical Materials Research
- Nonlinear Optical Materials Studies
- Peripheral Artery Disease Management
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Renal cell carcinoma treatment
- Fullerene Chemistry and Applications
- Cerebrovascular and Carotid Artery Diseases
- Vascular Anomalies and Treatments
- Tuberous Sclerosis Complex Research
- Liver Disease and Transplantation
- Vascular Procedures and Complications
- Near-Field Optical Microscopy
- Immune Cell Function and Interaction
- Pancreatic and Hepatic Oncology Research
- Quantum Dots Synthesis And Properties
- Renal and Vascular Pathologies
- Chalcogenide Semiconductor Thin Films
- Abdominal vascular conditions and treatments
- Cancer Immunotherapy and Biomarkers
- Congenital Heart Disease Studies
- Photochemistry and Electron Transfer Studies
- Venous Thromboembolism Diagnosis and Management
- Sexual function and dysfunction studies
Peking University First Hospital
2013-2024
Peking University
2013-2024
Creative Commons
2023
Fudan University
2019
Huashan Hospital
2019
CalliSpheres® Beads (CB) is the first drug-eluting bead (DEB) product in China. Our aim was to compare effect on pharmacokinetics of doxorubicin (DOX) and its local concentration between lipiodol emulsions CB process TACE rabbit livers. Twenty-five rabbits were distributed into two groups; Group 1 received with DOX, 2 loaded DOX (CBDOX). measured peripheral blood at different times after treatment. Livers sampled week month for embolization. distribution liver. The administration by CBDOX...
Abstract Background The benefits and tolerability of transarterial chemoembolization (TACE) combined with regorafenib as a second-line therapy has not been reported for unresectable hepatocellular carcinoma (HCC). This study aimed to explore the TACE in patients advanced HCC failure first-line treatment. Methods was multicenter retrospective progression after sorafenib and/or lenvatinib between 01/2019 04/2020 at four tertiary hospitals China. were treated TACE. Then, 5–7 days first TACE,...
478 Background: Immune-checkpoint inhibitors, in combination with targeted therapy and local therapy, have been developed as promising treatment for unresectable hepatocellular carcinoma (uHCC) of intermediate stage. This study aimed to assess the efficacy safety cadonilimab(a tetravalent PD-1/CTLA-4 bispecific antibody) plus Lenvatinib (Len) transarterial chemoembolization (TACE) HCC. Methods: open label, multicenter phase II trial enrolled patients histologically or clinically confirmed...
The purpose of this study was to evaluate the efficacy and safety transarterial embolization (TAE) for iatrogenic renal arterial pseudoaneurysm arteriovenous fistula at our center. Our retrospective analysis included 27 patients who received TAE between January 2006 2016. Data on demographics, type minimally invasive procedures, clinical manifestation, imaging features, procedure, perioperative details were collected. technical success rates analyzed. Furthermore, changes in serum creatinine...
Abstract Background/aim Recent studies have suggested that periportal location of percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is considered as one the independent risk factors local tumor progression (LTP). However, long-term therapeutic outcomes RFA first-line therapy single HCCand corresponding impacts on recurrence or are still unclear. Materials and methods From February 2011 to October 2020, a total 233 patients with nodular HCC ≤ 5 cm who underwent ±...
Background/Objective Treatment of hepatocellular carcinoma (HCC) with ablation alone often results in high rates recurrence and metastasis, reaching up to 25.9% within two years. Therefore, this study aimed examine the efficacy safety transarterial chemoembolization (TACE)-assisted multi-image guided radiofrequency (RFA) for treatment stage Ia HCC according China liver cancer staging (CNLC). Methods This enrolled analyzed a total 118 patients diagnosed HCC, each single nodular lesion no...
The charge carrier dynamics in the novel CdSe nanocluster films fabricated by a chemical deposition method was studied femtosecond pump–probe measurements. intensity dependent signals can be well described rate equation model. overall kinetic process is listed as follows: rapid electron trapping (<1 ps), Auger recombination, recombination of electrons surface states (∼46 ps) and long-lived trapped electron–hole recombination. When cluster radius large 27 nm, an induced transient...
To compare the long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation (TACE-RFA) with (RFA) monotherapy for small (≤3 cm) hepatocellular carcinomas (HCCs).A total 248 patients 329 HCC nodules who underwent TACE-RFA or RFA as only first-line treatment between January 2009 December 2020 were included in this study. The technical success, complications, survival rate, local tumor progression (LTP) rate compared two treatments.The 1-, 3- 5-year rates similar...
Purpose: To confirm the safety and effectiveness of IN.PACT Admiral drug-coated balloon (DCB) as a treatment for de novo native artery restenotic lesions in superficial femoral (SFA) and/or proximal popliteal Chinese subjects. Materials Methods: SFA China (ClinicalTrials.gov identifier NCT02118532) was single-arm, independently adjudicated, prospective, premarket study that enrolled 143 subjects (mean age 66.8±7.7 years; 107 men) at 15 centers. The predominant risk factors were hypertension...
Background/objective The aim of this study was to evaluate tumor progression and recurrence patterns radiofrequency ablation (RFA) with or without transarterial chemoembolization (TACE) for treating hepatocellular carcinoma (HCC) that meets Milan criteria. Methods This retrospective included consecutive HCC patients meeting criteria who underwent percutaneous RFA TACE as initial treatment at a tertiary academic center between December 2017 2022. Technical success rate, local recurrence-free...
Background Different strategies for hepatocellular carcinoma (HCC) may have distinct effects on the immune system. The aim of this research was to investigate changes in immunological function after transcatheter arterial chemoembolization (TACE) plus radiofrequency ablation (RFA) HCC patients. Methods A total 51 consecutive treatment-naïve patients enrolled study and 20 healthy subjects served as controls. therapeutic strategy selected according tumor stage general conditions. TACE...
Open surgery is the gold standard for treatment of aortoiliac occlusive disease (AIOD). Endovascular therapy has emerged as an attractive alternative AIOD due to its minimal invasiveness. The aims present study were investigate long-term patency endovascular and compare outcomes Transatlantic Inter-Society Consensus II (TASC II) A/B C/D lesions.Patients with (n=156) enrolled in this retrospective cohort study. Patency rates assessed at 12, 36, 60 months after procedure. Parameters...
Hepatocellular carcinoma is one of the leading causes cancer-related death worldwide. Recently, radiomics and radiogenomics have been introduced as novel dimensions in oncology research. In current review, we summarize clinical applications hepatocellular carcinoma.